<i>In Vivo</i> Syngeneic Tumor Models with Acquired Resistance to Anti–PD-1/PD-L1 Therapies
Morgane Denis(Université Claude Bernard Lyon 1), Charles Dumontet(Centre de Recherche en Cancérologie de Lyon)
Cited by 31
Related Papers
Antibody–drug conjugates come of age in oncology
|Nature Reviews Drug Discovery|2023|772
Adipose cells promote resistance of breast cancer cells to trastuzumab-mediated antibody-dependent cellular cytotoxicity
|Breast Cancer Research|2015|104